Skip to content
On this page:OverviewPublicationsResearchersInstitutionsOpen access
PICO Portalanswers from OpenAlex

Idera Pharmaceuticals (United States)

InstitutionResearch output, impact & collaborations

Idera Pharmaceuticals (United States) is a institution indexed in PICO Portal from OpenAlex.

What is known about Idera Pharmaceuticals (United States)?

PICO Portalrecord summary

Idera Pharmaceuticals (United States) is a research organisation in Cambridge, US. OpenAlex records 590 works and 101,094 citations for it. 196 researchers list it as their most recent affiliation.

How many works does Idera Pharmaceuticals (United States) have?

PICO Portalindexed works

Idera Pharmaceuticals (United States) has 590 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Idera Pharmaceuticals (United States) have?

PICO Portalcitation count

Idera Pharmaceuticals (United States) has 101,094 citations in the OpenAlex counts PICO Portal stores.

How many researchers are at Idera Pharmaceuticals (United States)?

PICO Portalresearcher count

Idera Pharmaceuticals (United States) has 196 researchers in the PICO Portal index.

What is the average h-index at Idera Pharmaceuticals (United States)?

PICO Portalavg h-index

Idera Pharmaceuticals (United States) has an average h-index of 72 in OpenAlex.

What is the ROR of Idera Pharmaceuticals (United States)?

PICO Portalror

The ROR for Idera Pharmaceuticals (United States) is on the source record.

What is the OpenAlex record for Idera Pharmaceuticals (United States)?

PICO Portalopenalex

The OpenAlex for Idera Pharmaceuticals (United States) is on the source record.

Who are the most-cited researchers behind Idera Pharmaceuticals (United States)?

PICO Portaltop researchers by citations
1
Sudhir Agrawal · DNA and Nucleic Acid Chemistry
440 works17,946 citations

What are the most-cited papers on Idera Pharmaceuticals (United States)?

PICO Portalmost cited works
Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: <i>In vitro</i> and <i>in vivo</i>  studies
Sudhir Agrawal, Zhiwei Jiang, Qiuyan Zhao, Denise R. Shaw, Qiuyin Cai, Allysen Roskey, Lakshmi S. Channavajjala, Carl Saxinger, Ruiwen Zhang
Proceedings of the National Academy of Sciences. 1997227 CitationsOPEN ACCESS
Antisense therapeutics
Sudhir Agrawal, Qiuyan Zhao
Current Opinion in Chemical Biology. 1998192 Citations
Effect of different chemically modified oligodeoxynucleotides on immune stimulation
Qiuyan Zhao, Jamal Temsamani, Patricia L. Iadarola, Zhiwei Jiang, Sudhir Agrawal
Biochemical Pharmacology. 1996176 Citations
Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration
Sudhir Agrawal, Xueshu Zhang, Zhihong Lu, Hui Zhao, Jeffrey M. Tamburin, Jieming Van, Hongying Cai, Robert B. Diasio, Ivan Habuš, Zhiwei Jiang, Radhakrishnan P. Iyer, Yu Dong, Ruiwen Zhang
Biochemical Pharmacology. 1995136 Citations

How much of the research on Idera Pharmaceuticals (United States) is open access?

PICO Portalopen access share
25%OPEN ACCESS
Gold
0%
Green
25%
Hybrid
0%
Bronze
0%
Closed
75%

Related on PICO Portal

470M+ articles · 14-day free trial